Nutrient Intake and Bone Mineral Density by Nutritional Status in Patients with Inflammatory Bowel Disease

Lim, Hee‐Sook; Kim, Hwa Jong; Hong, Su Jin; Kim, Soonkyung

doi:10.11005/jbm.2014.21.3.195

Cited by 26 publications

(22 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to the BMI-classification of the World Health Organization (WHO), a BMI less than 18.5 kg/m² was considered as underweight, between 18.5 kg/m² to 25.0 kg/m² as normal weight, between 25.0 kg/ m² to 30.0 kg/m² as overweight (pre-obese) and over 30.0 kg/m² as obese [28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45].…”

Section: Nutritional Statusmentioning

confidence: 99%

See 1 more Smart Citation

Dietary Habits and Nutrient Intake in Patients with Inflammatory Bowel Disease

Schink¹,

Mirsch²,

Dieterich³

et al. 2017

J Nutr Food Sci

View full text Add to dashboard Cite

Patients with inflammatory bowel diseases (IBD) are often affected by nutrient deficiencies. Besides a limited nutrient intake by disease-related side effects and malabsorption, the influence of diets and dietary changes is much discussed. However, data about food patterns are mostly based on subjective declarations. Therefore, this study aimed to achieve a detailed and objective analysis of nutrient intake and individual food habits in IBD, a prerequisite for an appropriate nutritional intervention in risk patients. One hundred IBD patients (n=70 Crohn's disease (CD), n=30 ulcerative colitis (UC)) and 30 healthy controls (HC) were included in the study. All participants filled in a disease-related and food frequency questionnaire. Fifteen healthy controls and 71 IBD patients additionally completed a questionnaire for self-imposed food restrictions. Most IBD patients and healthy controls showed a normal body mass index. However, within the IBD group, UC patients were more often overweight than CD patients (p=0.007). Food restrictions were common in all participants, but significantly more IBD patients restricted their consumption of fast food (p=0.037), fruits and vegetables (p=0.019). Especially CD patients with acute relapse consumed less fruits and vegetables (p=0.035). Contrary to subjective assessment, an objective survey of dietary intake revealed a significantly higher sugar intake of IBD patients compared to healthy controls (p<0.001) with an increased ingestion of sugar/confectionery (p=0.041), soft/isotonic drinks (p<0.001) and fruit/vegetable juices (p=0.022). Additionally, IBD patients ingested higher amounts of salt than healthy controls (p=0.005). Both groups showed an insufficient ingestion of folate, vitamin D and pantothenic acid.In conclusion, self-managed food restrictions appear to be common in IBD patients. The huge discrepancy between the subjective view of dietary habits and objective evaluation of nutrient intake indicates that nutrient assessment should be based on objective tools. A repetitive professional nutritional counseling is recommended to prevent and treat nutritional deficiencies.

show abstract

Section: Nutritional Statusmentioning

confidence: 99%

“…Since milk and dairy products are important sources of calcium and vitamin D, a long-term restriction can cause deficiency or complications like osteoporosis in IBD patients [44]. Although most vitamin D is supplied by synthesis in the skin, the oral intake is very important.…”

Section: Food Group Hc Total Ibd Ibd (Intake In [G/d]) CD Ucmentioning

confidence: 99%

Dietary Habits and Nutrient Intake in Patients with Inflammatory Bowel Disease

Schink¹,

Mirsch²,

Dieterich³

et al. 2017

J Nutr Food Sci

View full text Add to dashboard Cite

show abstract

“…Lower calcium intake and absorption, as well as vitamin K nutritional deficiencies, may contribute to the bone loss (132) .…”

Section: Introductionmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management

Mirza

Canalis

2015

European Journal of Endocrinology

267

164

View full text Add to dashboard Cite

Osteoporosis is a skeletal disorder characterized by decreased bone mineral density and compromised bone strength predisposing to an increased risk of fractures. Although idiopathic osteoporosis is the most common form of osteoporosis, secondary factors may contribute to the bone loss and increased fracture risk in patients presenting with fragility fractures or osteoporosis. Several medical conditions and medications significantly increase the risk for bone loss and skeletal fragility. This review focuses on some of the common causes of osteoporosis, addressing the underlying mechanisms, diagnostic approach and treatment of low bone mass in the presence of these conditions.

show abstract

“…Some claim that during the later stages of the disease the remaining inflammation becomes trapped behind a closed or repaired blood–brain barrier and is not derived peripherally [32]. Our current results may indirectly suggest that the systemic inflammation in MS is not sufficient to increase bone loss over time as is seen in other diseases in which systemic inflammation dominates, such as inflammatory bowel disease [33]. Another possible explanation for the lack of significant difference between MS and HSP/HA patients could be that inflammation may also play a role in HSP/HA.…”

Section: Discussionmentioning

confidence: 82%

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study

et al. 2016

View full text Add to dashboard Cite

BackgroundAlthough disability is considered the main cause of low bone mineral density (BMD) in multiple sclerosis (MS), other factors related to the disease process or treatment could also be involved. The aim of this study was to assess whether patients with MS are more likely to develop low BMD (osteopenia or osteoporosis) than patients with the non-inflammatory neurological diseases Hereditary Spastic Paraplegia (HSP) and Hereditary Ataxia (HA).MethodsWe performed a case control study comparing BMD (spine, hip and total body) and biochemical measures of bone metabolism in 91 MS patients and 77 patients with HSP or HA, matched for age, gender and disability. Both patient groups had lived with the disease for at least 10 years.ResultsIn total 74.7% of the patients with MS and 75.3% of the patients with HSP or HA had osteopenia (−2.5 < T- score < −1.0) or osteoporosis (T- score ≤ −2.5) in one or more sites. Osteoporosis was more common in patients with MS than with HSP/HA (44.0 vs 20.8%, p =0.001). This difference was not significant after correction for confounders (p = 0.07), nor were any of the biochemical markers.ConclusionMost patients with disabling neurological diseases like MS and HSP/HA develop osteopenia or osteoporosis. MS patients had osteoporosis more frequently than HA/HSP patients, though the difference was not significant after adjusting for confounders. Osteoporosis and bone health should be considered in all patients with both inflammatory and degenerative chronic neurological diseases.Electronic supplementary materialThe online version of this article (doi:10.1186/s12883-016-0771-4) contains supplementary material, which is available to authorized users.

show abstract

Nutrient Intake and Bone Mineral Density by Nutritional Status in Patients with Inflammatory Bowel Disease

Cited by 26 publications

References 28 publications

Dietary Habits and Nutrient Intake in Patients with Inflammatory Bowel Disease

Dietary Habits and Nutrient Intake in Patients with Inflammatory Bowel Disease

MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study

Contact Info

Product

Resources

About